• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

2017 Valneva Annual Business Report

Download 2017 Valneva Annual Business Report

June 7, 2018  

Valneva Announces the Availability of Documentation for its Meeting of Shareholders


— Stock information


— May 17, 2018
Valneva Reports Strong Q1 Results and Continues to Advance Key R&D Programs

Read more
— Financial Calendar

June 28, 2018
Shareholders' Meeting

August 2, 2018
HY 2018 Financial Statements

See all dates


learn more
play video Company Video

– Upcoming conferences

October 29-31
World Vaccine Congress Europe, Lisbon
Please update your browser...